Literature DB >> 15375814

Access to inpatient rehabilitation after violence-related traumatic brain injury.

Peter C Esselman1, Sureyya S Dikmen, Kathleen Bell, Nancy R Temkin.   

Abstract

OBJECTIVES: To examine injury characteristics, demographics, and discharge disposition after traumatic brain injury of violent or nonviolent cause.
DESIGN: Cohort study.
SETTING: Level I trauma center. PARTICIPANTS: Patients (N=1807) admitted with a Head Abbreviated Injury Score (AIS) of 2 or more over a 2-year period.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Injury cause was classified as violent or nonviolent. Discharge disposition was classified as home, inpatient rehabilitation, skilled nursing facility (SNF), and other.
RESULTS: The violence group was more likely to be male, to include individuals from diverse racial groups, to have an alcohol level above the legal limit, to have a more severe Head AIS, and to have Medicaid funding and equal access to inpatient rehabilitation compared with the nonviolence group. The violence group, though, was more likely to be discharged to home than to inpatient rehabilitation and more likely to be discharged to inpatient rehabilitation than to an SNF. The nonviolence group had a longer acute care length of stay and a higher rate of injuries to other body systems.
CONCLUSIONS: People with violence-related injuries often present unique rehabilitation challenges. After accounting for injury severity and demographics, there was no evidence of bias against the violently injured in gaining access to inpatient rehabilitation services.

Entities:  

Mesh:

Year:  2004        PMID: 15375814     DOI: 10.1016/j.apmr.2003.10.018

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  1 in total

Review 1.  Epidemiology of traumatic brain injury and subarachnoid hemorrhage.

Authors:  José León-Carrión; María del Rosario Domínguez-Morales; Juan Manuel Barroso y Martín; Francisco Murillo-Cabezas
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.